Impact of surgical aortic valve replacement and transcatheter aortic valve implantation on cardiovascular and cerebrovascular controls: A pilot study

被引:0
|
作者
Bari, Vlasta [1 ,2 ]
Gelpi, Francesca [1 ]
Cairo, Beatrice [1 ]
Anguissola, Martina [2 ]
Acerbi, Elena [3 ]
Squillace, Mattia [3 ]
De Maria, Beatrice [4 ]
Bertoldo, Enrico Giuseppe [5 ]
Fiolo, Valentina [5 ]
Callus, Edward [1 ,5 ]
De Vincentiis, Carlo [6 ]
Bedogni, Francesco [3 ]
Ranucci, Marco [2 ]
Porta, Alberto [1 ,2 ]
机构
[1] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy
[2] IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy
[3] IRCCS Policlin San Donato, Dept Clin & Intervent Cardiol, Milan, Italy
[4] IRCCS Istituti Clinici Scientif Maugeri, Milan, Italy
[5] IRCCS Policlin San Donato, Clin Psychol Serv, Milan, Italy
[6] IRCCS Policlin San Donato, Dept Cardiac Surg, Milan, Italy
来源
PHYSIOLOGICAL REPORTS | 2024年 / 12卷 / 17期
关键词
active standing; aortic valve stenosis; autonomic nervous system; baroreflex; blood flow; cerebral autoregulation; heart rate variability; mean arterial blood pressure; HEAD-UP TILT; SYMPATHETIC-NERVE ACTIVITY; CEREBRAL AUTOREGULATION; BAROREFLEX SENSITIVITY; RATE-VARIABILITY; ATRIAL-FIBRILLATION; PERIOD VARIABILITY; AUTONOMIC FUNCTION; BLOOD-PRESSURE; FLOW-VELOCITY;
D O I
10.14814/phy2.70028
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) are options in severe aortic valve stenosis (AVS). Cardiovascular (CV) and cerebrovascular (CBV) control markers, derived from variability of heart period, systolic arterial pressure, mean cerebral blood velocity and mean arterial pressure, were acquired in 19 AVS patients (age: 76.8 +/- 3.1 yrs, eight males) scheduled for SAVR and in 19 AVS patients (age: 79.9 + 6.5 yrs, 11 males) scheduled for TAVI before (PRE) and after intervention (POST, <7 days). Left ventricular function was preserved in both groups. Patients were studied at supine resting (REST) and during active standing (STAND). We found that: (i) both SAVR and TAVI groups featured a weak pre-procedure CV control; (ii) TAVI ensured better CV control; (iii) cerebral autoregulation was working in PRE in both SAVR and TAVI groups; (iv) SAVR and TAVI had no impact on the CBV control; (v) regardless of group, CV and CBV control markers were not influenced by STAND in POST. Even though the post-procedure preservation of both CV and CBV controls in TAVI group might lead to privilege this procedure in patients at higher risk, the missing response to STAND suggests that this advantage could be insignificant.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Transcatheter aortic valve implantation (TAVI)
    Weber, M.
    Werner, N.
    KARDIOLOGE, 2019, 13 (01): : 51 - 60
  • [42] Innovations in Cardiovascular Patient Care: Transcatheter Aortic Valve Replacement
    McGhee, Melanie
    NURSING CLINICS OF NORTH AMERICA, 2015, 50 (04) : 713 - +
  • [43] Evolution of Transcatheter Aortic Valve Replacement
    Bourantas, Christos V.
    Serruys, Patrick W.
    CIRCULATION RESEARCH, 2014, 114 (06) : 1037 - 1051
  • [44] Comparison of Transcatheter Aortic Valve Implantation versus Surgical Aortic Valve Replacement to Improve Quality of Life in Patients >70 Years of Age with Severe Aortic Stenosis
    Kocaaslan, Cemal
    Ketenci, Bulend
    Yilmaz, Mehmet
    Kehlibar, Tamer
    Memetoglu, Mehmet Erdem
    Ertas, Gokhan
    Eren, Mehmet
    Demirtas, Mahmut Murat
    BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY, 2016, 31 (01) : 1 - 6
  • [45] Transcatheter Aortic Valve Implantation Impact on Clinical and Valve-Related Outcomes
    Webb, John G.
    Altwegg, Lukas
    Boone, Robert H.
    Cheung, Anson
    Ye, Jian
    Lichtenstein, Samuel
    Lee, May
    Masson, Jean Bernard
    Thompson, Christopher
    Moss, Robert
    Carere, Ron
    Munt, Brad
    Nietlispach, Fabian
    Humphries, Karin
    CIRCULATION, 2009, 119 (23) : 3009 - 3016
  • [46] Transcatheter aortic valve implantation in patients with bicuspid aortic valve: a series of cases
    Kosek, Mikolaj
    Witkowski, Adam
    Dabrowski, Maciej
    Jastrzebski, Jan
    Michalowska, Ilona
    Chmielak, Zbigniew
    Demkow, Marcin
    Ksiezycka-Majczynska, Ewa
    Michalek, Piotr
    Szymanski, Piotr
    Hryniewiecki, Tomasz
    Stepinska, Janina
    Sitkowska-Rysiak, Ewa
    Ruzyllo, Witold
    KARDIOLOGIA POLSKA, 2015, 73 (08) : 627 - 636
  • [47] Transcatheter aortic valve implantation versus surgical aortic valve replacement in severe aortic stenosis patients at low surgical mortality risk: a cost-effectiveness analysis in Belgium
    Dubois, Christophe
    Adriaenssens, Tom
    Annemans, Lieven
    Bosmans, Johan
    Callebaut, Britt
    Candolfi, Pascal
    Cornelis, Kristoff
    Delbaere, Alexis
    Green, Michelle
    Kefer, Joelle
    Lancellotti, Patrizio
    Rosseel, Michael
    Shore, Judith
    Van Der Heyden, Jan
    Vermeersch, Sebastian
    Wyffels, Eric
    ACTA CARDIOLOGICA, 2024, 79 (01) : 46 - 57
  • [48] Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement
    Chakravarty, Tarun
    Patel, Akshar
    Kapadia, Samir
    Raschpichler, Matthias
    Smalling, Richard W.
    Szeto, Wilson Y.
    Abramowitz, Yigal
    Cheng, Wen
    Douglas, Pamela S.
    Hahn, Rebecca T.
    Herrmann, Howard C.
    Kereiakes, Dean
    Svensson, Lars
    Yoon, Sung-Han
    Babaliaros, Vasilis C.
    Kodali, Susheel
    Thourani, Vinod H.
    Alu, Maria C.
    Liu, Yangbo
    McAndrew, Thomas
    Mack, Michael
    Leon, Martin B.
    Makkar, Raj R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (09) : 1190 - 1200
  • [49] Incidence of arrhythmias and impact of permanent pacemaker implantation in hospitalizations with transcatheter aortic valve replacement
    Doshi, Rajkumar
    Decter, Dean H.
    Meraj, Perwaiz
    CLINICAL CARDIOLOGY, 2018, 41 (05) : 640 - 645
  • [50] Management of bicuspid aortic valve disease in the transcatheter aortic valve implantation era
    Jahangiri, Marjan
    Prendergast, Bernard
    HEART, 2024, : 1291 - 1297